Dernière mise à jour du site :
BMC Cancer 2023; 23(1): 440 ·
Background Current studies on the role of ARHGAP39 mainly focused on its effect on neurodevelopment. However, there are few studies on the comprehensive analysis of ARHGAP39 in breast cancer.Methods ARHGAP39 expression level was analyzed based on the Cancer Genome Atlas…
Journal of Ovarian Research 2023; 16(1): 95 ·
Background Ovarian cancer has the worst outcome among gynecological malignancies; therefore, biomarkers that could contribute to the early diagnosis and/or prognosis prediction are urgently required. In the present study, we focused on the secreted protein spondin-1 (SPON1) and clarified the…
Cancer imaging 2023; 23(1): 54 ·
Background Axillary lymph node (ALN) metastasis is used to select treatment strategies and define the prognosis in breast cancer (BC) patients and is typically assessed using an invasive procedure. Noninvasive, simple, and reliable tools to accurately predict ALN status are…
BMC Cancer 2023; 23(1): 489 ·
Background The potential treatment effects of heat shock protein 90 (Hsp90) inhibitors in ovarian cancer (OC) are controversial. This research aims to investigate the relationship between the level of Hsp90 in peripheral blood and the prognosis of OC patients, as…
